Lisa Russ Sinclair
About Lisa Russ Sinclair
Lisa Russ Sinclair serves as the Head of Corporate & Commercial Strategy at Rallybio and is the SVP of Corporate Operations at Arvinas. With over 20 years of experience in portfolio strategy and new product development, she has a strong background in rare disease therapeutics and has held various leadership roles in prominent pharmaceutical companies.
Current Role at Rallybio
Lisa Russ Sinclair serves as the Head of Corporate & Commercial Strategy at Rallybio, a position she has held since 2019. In this role, she has implemented strategic capabilities specifically for rare disease therapeutics, contributing to the company's portfolio growth and performance targets. Sinclair's leadership in this area reflects her extensive experience in the pharmaceutical industry, particularly in developing strategies that align with corporate goals.
Professional Experience
Before joining Rallybio, Sinclair held various significant positions in the pharmaceutical sector. She worked at Arvinas as SVP Corporate Operations since 2022. Prior to that, she was with SpringWorks Therapeutics as Head of Program and Alliance Management in 2018-2019. Sinclair also served as Vice President of R&D Strategy at Alexion Pharmaceuticals from 2014 to 2017 and held roles at Pfizer, including Senior Director and Portfolio Director in Cardiovascular and Metabolic Disease from 2005 to 2009.
Education and Expertise
Lisa Russ Sinclair earned a Bachelor of Arts in Business Administration with a focus on Marketing from the University of Vermont. She has over 20 years of experience in portfolio strategy and new product development, covering all stages from pre-clinical to product launch. Her educational background and extensive industry experience equip her with the knowledge to lead strategic initiatives effectively.
Leadership and Values
Sinclair is passionate about equality and the development of people, which is evident in her leadership style. She emphasizes the importance of fostering an inclusive environment that supports team growth and collaboration. Her approach to leadership reflects her commitment to not only achieving corporate objectives but also nurturing talent within her teams.
Achievements in Rare Disease Therapeutics
Throughout her career, Lisa Russ Sinclair has been recognized for her ability to build and implement operational plans in the field of rare disease therapeutics. Her strategic contributions have significantly impacted portfolio growth and performance targets at Rallybio and other organizations she has been part of, showcasing her expertise in navigating complex therapeutic areas.